Significant racial and ethnic disparities exist in the presentation and treatment of pulmonary arterial hypertension, with minority groups facing differences in disease subtype and lower rates of specific therapies.
Idea 1:* Highlights critical gaps in equitable PAH care delivery.
This study explores the racial and ethnic differences in presentation, severity, and treatment of patients with pulmonary arterial hypertension (PAH) in a large multicenter registry. African American and Hispanic patients are more likely to present with associated PAH compared to non-Hispanic whites. Hispanic patients with PAH were less likely to be treated with PAH-specific medications compared to non-Hispanic whites.
No takes yet. Share an insight, caveat, or question.
Al‐Naamani et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: